| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |